ERS International Congress, Paris 2018

Browse by day: Saturday, 15.09.2018 Sunday, 16.09.2018 Monday, 17.09.2018 Tuesday, 18.09.2018 Wednesday, 19.09.2018		View the presentations you missed during Congress! More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.

Clinical aspects of pulmonary hypertension

Thematic Poster
Chairs: L. Savale (Le Kremlin-Bicêtre, France), F. Lador (Genève 14, Switzerland), I. Lang (Wien, Austria), S. Gaine (Dublin, Ireland)

Download all media

Identifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI) V. Cottin (Lyon, France), S. Teal (Berlin, Germany), D. Avot (Courbevoie, France), L. Lévy-Bachelot (Courbevoie, France), C. Baxter (Hoddesdon, United Kingdom), A. Palmero (Oullins, France), L. Catella (Oullins, France), S. Bénard (Oullins, France), O. Sitbon (Le Kremlin-Bicêtre, France)
Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a psychiatric disorder H. Tajima (Chiba, Japan), H. Kasai (Chiba, Japan), H. Miwa (Chiba, Japan), A. Naitou (Chiba, Japan), T. Sugiura (Chiba, Japan), S. Sakao (Chiba, Japan), N. Tanabe (Chiba, Japan), K. Tatsumi (Chiba, Japan)
Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism V. Dimitrova (Varna, Bulgaria), D. Petkova (Varna, Bulgaria), V. Stratev (Varna, Bulgaria), T. Dobreva (Varna, Bulgaria)
Good outcomes following elective lower limb orthopaedic surgery in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension M. Ming (Sheffield, United Kingdom), A. Nair (Sheffield, United Kingdom), S. Saunders (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), C. Elliot (Sheffield, United Kingdom), A. Charalampopoulos (Sheffield, United Kingdom), I. Sabroe (Sheffield, United Kingdom), R. Lewis (Sheffield, United Kingdom), I. Armstrong (Sheffield, United Kingdom), P. Sephton (Sheffield, United Kingdom), N. Hamilton (Sheffield, United Kingdom), R. Kerry (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom)
Anomalous pulmonary venous drainage (APVD) in patients with suspected pulmonary hypertension (PH) R. Lewis (Sheffield, United Kingdom), C. Billings (Sheffield, United Kingdom), C. Johns (Sheffield, United Kingdom), J. Hurdman (Sheffield, United Kingdom), N. Hamilton (Sheffield, United Kingdom), C. Elliot (Sheffield, United Kingdom), A. Charalampopoulos (Sheffield, United Kingdom), I. Sabroe (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom)
Survival in portopulmonary hypertension (PoPH) in the era of modern PAH-targeted therapy L. Savale (Le Kremlin-Bicêtre, France), N. Ebstein (Le Kremlin-Bicêtre, France), M. Jevnikar (Le Kremlin-Bicêtre, France), X. Jaïs (Le Kremlin-Bicêtre, France), F. Parent (Le Kremlin-Bicêtre, France), A. Boucly (Le Kremlin-Bicêtre, France), G. Simonneau (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France), M. Humbert (Le Kremlin-Bicêtre, France), O. Sitbon (Le Kremlin-Bicêtre, France)
Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension D. Kiely (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), O. Doyle (London, United Kingdom), V. Salvatelli (London, United Kingdom), F. Daniels (London, United Kingdom), E. Drage (London, United Kingdom), H. Jenner (London, United Kingdom), J. Rigg (London, United Kingdom), C. Schmitt (Brentford, United Kingdom), Y. Samyshkin (Brentford, United Kingdom), R. Bergemann (Brentford, United Kingdom)
Possible pathophysiological role of vitamin D deficit in pulmonary arterial hypertension M. Callejo (Madrid, Spain), D. Morales-Cano (Madrid, Spain), G. Mondejar-Parreño (Madrid, Spain), B. Barreira (Madrid, Spain), S. Esquivel-Ruiz (Madrid, Spain), L. Moreno (Madrid, Spain), P. Escribano (Madrid, Spain), I. Blanco (Barcelona, Spain), J. Barberà (Barcelona, Spain), A. Cogolludo (Madrid, Spain), F. Perez-Vizcaino (Madrid, Spain)
PEGASUS - the effects of commercial air travel on patients suffering from pulmonary hypertension - a prospective, multicenter, multinational study L. Becker (Giessen, Germany), J. Grimminger (Giessen, Germany), M. Richter (Giessen, Germany), N. Sommer (Giessen, Germany), K. Tello (Giessen, Germany), W. Seeger (Giessen, Germany), H. Klose (Hamburg, Germany), S. Ulrich (Zurich, Switzerland), M. Halank (Dresden, Germany), C. Opitz (Berlin, Germany), E. Gruenig (Heidelberg, Germany), A. Ghofrani (Giessen, Germany), H. Gall (Giessen, Germany)
Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK) I. Armstrong (Sheffield, United Kingdom), C. Billings (Sheffield, United Kingdom), S. Clayton (Sheffield, United Kingdom), J. Yorke (Manchester, United Kingdom), C. Harries (London, United Kingdom), D. Kiely (Sheffield, United Kingdom)
The phenotype of the Adult Mexican Patient with Pulmonary Arterial Hypertension: Baseline characteristics of the REMEHIP Registry. The REMEHIP Investigators. T. Pulido Zamudio (Mexico City, Mexico), J. Sandoval (Mexico City, Mexico), C. Sanchez Z Diaz (Monterrey, Mexico), A. Ramirez (Monterrey, Mexico), M. Beltran (Tijuana, Mexico), M. Seoane (Mexico City, Mexico), J. Moreno (Monterrey, Mexico), P. GutiéRrez-Fajardo (Guadalajara, Mexico), J. Elizalde (Mexico City, Mexico), G. Cueto (Mexico City, Mexico), H. GarcíA (Mexico City, Mexico), R. Parra (Guadalajara, Mexico)
Ventricular mass index predicts mortality in incident patients with PAH C. Simpson (Baltimore, United States of America), R. Damico (Baltimore, United States of America), S. Mathai (Baltimore, United States of America), T. Kolb (Baltimore, United States of America), R. Khair (Baltimore, United States of America), S. Zimmerman (Baltimore, United States of America), P. Hassoun (Baltimore, United States of America)
Cancer incidence in incident patients with precapillary pulmonary hypertension. E. Bravos (Saint-Etienne, France), V. Cottin (Lyon, France), C. Dauphin (Clermont-Ferrand, France), H. Bouvaist (Grenoble, France), J. Traclet (Lyon, France), R. Trésorier (Clermont-Ferrand, France), S. Bezzeghoud (Saint-Etienne, France), K. Ahmad (Lyon, France), S. Accassat (Saint-Etienne, France), E. De Magalhaes (Saint-Etienne, France), J. Mornex (Lyon, France), C. Pison (Grenoble, France), L. Bertoletti (Saint-Etienne, France)
Determinants and prognostic value of kidney disease in pulmonary arterial hypertension V. Cottin (lyon, France), L. Bitker (lyon, France), F. Sens (lyon, France), C. Payet (lyon, France), S. Turquier (lyon, France), J. Traclet (lyon, France), K. Ahmad (lyon, France), S. Zeghmar (lyon, France), J. Mornex (lyon, France), A. Duclos (lyon, France), L. Juillard (lyon, France)
Pulmonary Hypertension in Hemodialysis Patients M. Abdelghany (Assiut, Egypt), A. Bahei (Assiut, Egypt), W. Hosny (Assiut, Egypt)
Critical care admissions in patients with pulmonary arterial hypertension. L. Price (London, United Kingdom), C. Mccabe (London, United Kingdom), S. Herbert (Bristol, United Kingdom), T. Aw (London, United Kingdom), D. Alexander (London, United Kingdom), S. Price (London, United Kingdom), S. Ledot (London, United Kingdom), A. Kempny (London, United Kingdom), C. Harries (London, United Kingdom), J. Wort (London, United Kingdom), K. Dimopoulos (London, United Kingdom)
EARLIER: End tidal carbon dioxide for earlier detection of pulmonary hypertension S. Herbst (Giessen, Germany), M. Richter (Giessen, Germany), N. Sommer (Giessen, Germany), K. Tello (Giessen, Germany), W. Seeger (Giessen, Germany), A. Ghofrani (Giessen, Germany), H. Gall (Giessen, Germany)
Capillaroscopic findings in patients with pulmonary arterial hypertension L. Bonola (México, Mexico), J. Sandoval (México, Mexico), T. Pulido (México, Mexico), N. Zayas (México, Mexico)
Cirrhose cardiaque in pulmonary hypertension- a case series. M. Lerche (Leipzig , Germany), A. Frille (Leipzig, Germany), H. Wirtz (Leipzig, Germany), J. Wiegand (Leipzig, Germany), V. Keim (Leipzig, Germany), T. Karlas (Leipzig, Germany), S. Tegelkamp (Leipzig, Germany), H. Seyfarth (Leipzig, Germany)
Epidemiological and Clinical aspects of pulmonary arterial hypertension (PAH) R. Yahiaoui (Algers, Algeria), Z. Bennoui (Algers, Algeria), D. Hakem (Algers, Algeria), R. Amrane (Algers, Algeria), R. Boughrarou (Algers, Algeria)